Argeris N. Karabelas, Chairman of the Board at Vanda Pharmaceuticals Inc. (VNDA), sold 424,150 shares at $25.18 ($10.7M) on 2006-12-12, disclosed to the SEC on 2006-12-14.
Open-market sale of $10.7M VNDA by Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.18 | 27,230 | $686K | 6.4% |
| 2 | $25.18 | 396,920 | $10.0M | 93.6% |
| Total | $25.18 avg | 424,150 | $10.7M | 100% |
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |